)
)
Divi’s Laboratories Investor Relations Material
Latest events
Q2 24/25
Divi’s Laboratories
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Divi’s Laboratories Limited
Access all reports
DiviS Laboratories Ltd is engaged in the manufacture of Active Pharma Ingredients (APIs) and intermediates. The company offers bulk drug intermediates, APIs, and bulk drug intermediate blends for commercial and laboratory use. DiviS Laboratories' products are used for the synthesis of anti-cancer medicines, anti-infective agents and other pharmaceuticals.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
DIVISLAB
Country
🇮🇳 India